Subscribe
shutterstock_1513301072_bernsten-1
shutterstock_1513301072_bernsten
23 June 2022Sarah Speight

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More on this story

Americas
US supports delay to COVID waiver extension
8 December 2022   Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about the controversial patent waiver.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
Big Pharma
Governments may have to reserve 20% of vaccines: WHO
2 February 2023   Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

More features

CREATES Act unfairly tips the scales to generics
Pharma giants seek closure on COVID-19 vaccine rows
Trump’s return sparks calls for pro-patent agenda
Comparing life sciences IP in Brazil and the US
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Cooley adds ex-Gowling partner
GSK fires pair of COVID and RSV lawsuits at Moderna